{"schema_version": 1, "id": "ny-nonmetropolitan-area/life-sciences/2026-10", "product": "Labor Market Pulse", "metro": {"geography_id": 384, "label": "NY NONMETROPOLITAN AREA", "slug": "ny-nonmetropolitan-area"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-10", "public_after": "2026-10-01", "frozen_at": "2026-11-03T04:32:42.750569+00:00", "headline": "Nonmetro NY life sciences employers lose ground to suburban clusters.", "headline_summary": "Validation Engineer pay is up significantly to $121,750 against a $106,478 national median, while Regulatory Affairs Specialist pay fell to $96,065 even as the role remains among the hardest to fill nationally.", "key_indicators": [{"label": "Validation Engineer advertised pay", "value": "$121,750", "context": "vs $106,478 national median, up significantly"}, {"label": "Regulatory Affairs Specialist pay", "value": "$96,065", "context": "Down significantly, below $103,780 national"}, {"label": "National biopharma active recruiting", "value": "64%", "context": "Of organizations surveyed, per national industry data"}, {"label": "National quit rate", "value": "1.9%", "context": "Signals candidates staying put despite open roles"}], "takeaways": [{"headline": "Nonmetro sites compete against suburban hubs and each other alike.", "body": "CBRE data showing Long Island and NY suburbs posting the fastest life sciences employment growth in 2024-2025 means nonmetro employers are drawing from a pool actively being pulled toward Tarrytown, Rensselaer and East Greenbush expansion. Retention plans for quality and manufacturing staff should assume active outreach from these growing clusters."}, {"headline": "Regulatory Affairs pay is softening even as the role stays hard to fill.", "body": "Metro advertised median for Regulatory Affairs Specialist fell to $96,065, down significantly and now below the $103,780 national median, despite national reporting that regulatory affairs remains among the hardest pharma roles to fill in 2026. Falling advertised pay alongside persistent scarcity may suggest employers are restructuring the role's seniority mix or leaning harder on remote hires while urgency to fill it stays high."}, {"headline": "Validation Engineer pay is pulling ahead of the national market.", "body": "Metro median of $121,750 is up significantly and now runs well above the $106,478 national median, consistent with sustained biologics manufacturing investment described in national reporting. Validation and automation expertise tied to CDMO and manufacturing build-out looks like a premium line item worth isolating in compensation reviews, separate from generic engineering benchmarks."}, {"headline": "Low quit rates mean open roles stay open longer.", "body": "National quit rate holding at 1.9% while 64% of biopharma organizations report active recruiting points to a market where growth plans outpace available movers. Headcount planning in nonmetro facilities should build in longer time-to-fill assumptions for specialized regulatory, clinical and bioprocess roles, since pay alone is unlikely to accelerate hiring."}], "local_conditions": "Nonmetropolitan New York counties face a structurally thinner life sciences labor pool than the Capital Region or Long Island, and this month's statewide 109% surge in biopharma job postings (a signal of hiring demand; one ad often covers several openings) is concentrated in suburban and metro facility clusters, widening the recruiting radius employers must cover to fill specialized roles. Statewide nonfarm employment softness through July \u2014 enough to trigger the minimum wage freeze mechanism \u2014 has not relieved life sciences hiring pressure, since the sector's vacancy problem is tied to credentialing requirements that persist regardless of overall labor supply.", "implications": "Thin local candidate density in nonmetro counties means life sciences employers here are effectively competing against Capital Region, Hudson Valley and Long Island postings for the same regulatory, clinical and manufacturing talent pools, with commuting distance and relocation cost working against smaller or rural-sited operations. Build-vs-outsource calculus shifts further toward CDMO and CRO partnerships for facilities that cannot credibly compete on proximity to talent clusters like Tarrytown, Rensselaer or Pearl River. Organizations should evaluate whether remote-eligible functions \u2014 clinical data management, biostatistics, regulatory writing \u2014 can be structured to recruit statewide, extending reach beyond commuting range of a nonmetro site.", "looking_ahead": [{"category": "Worth watching", "body": "Whether the statewide minimum wage freeze triggers any downstream compression on entry-level lab technician and quality technician pay in nonmetro counties, where Lab Technician advertised pay already sits below the national median and trending down."}, {"category": "Emerging pressure point", "body": "Continued suburban and metro-area facility expansion (Pearl River, Tarrytown, Rensselaer) may draw nonmetro-based regulatory and manufacturing staff toward shorter commutes and higher-density employer clusters, accelerating turnover risk for rural-sited operations."}, {"category": "Potential inflection point", "body": "Statewide private-sector job losses (-16,300 year-to-date in NYC) have not yet shown up as slack in life sciences hiring; watch whether broader labor market softening eventually loosens the specialist talent market or remains sector-isolated."}, {"category": "Early indicator", "body": "InvaGen Pharmaceuticals' October WARN filing (205 workers, Central Islip) is a reminder that even amid sector hiring strength, site-level consolidation can release specialized manufacturing and quality talent into the regional pool with little notice."}], "roles": [{"role": "Research Scientist", "data_scope": "metro", "metro_p25": 95646.0, "metro_p50": 131354.0, "metro_p75": 151375.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 130339.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 72847.0, "metro_p50": 95900.0, "metro_p75": 101994.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 90065.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "metro", "metro_p25": 41365.0, "metro_p50": 45008.4, "metro_p75": 48230.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 47840.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Regulatory Affairs Specialist", "data_scope": "metro", "metro_p25": 68963.5, "metro_p50": 96064.6, "metro_p75": 116373.0, "metro_trend_direction": "down", "metro_trend_magnitude": "significant", "national_p50": 103779.6, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Clinical Data Manager", "data_scope": "metro", "metro_p25": 105756.25, "metro_p50": 132786.0, "metro_p75": 145555.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 123653.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Biostatistician", "data_scope": "metro", "metro_p25": 107702.0, "metro_p50": 131960.6, "metro_p75": 171248.25, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 131958.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Validation Engineer", "data_scope": "metro", "metro_p25": 92345.0, "metro_p50": 121750.0, "metro_p75": 165360.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 106478.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}], "industry_snapshot": [], "citations": [{"source_name": "Provided advertised pay data", "source_url": null, "statement": "Validation Engineer and Regulatory Affairs advertised pay figures"}, {"source_name": "CBRE", "source_url": null, "statement": "Long Island and NY suburbs posted fastest life sciences employment growth 2024-2025"}, {"source_name": "Industry biopharma labor market survey", "source_url": null, "statement": "64% of biopharma organizations actively recruiting, national quit rate 1.9%"}, {"source_name": "Job posting market data", "source_url": null, "statement": "NY biopharma job postings surged 109% year over year"}, {"source_name": "NY WARN Notice tracker", "source_url": null, "statement": "InvaGen Pharmaceuticals WARN filing for 205 workers in Central Islip"}, {"source_name": "Washington Post", "source_url": null, "statement": "NY statewide job losses triggered minimum wage freeze mechanism"}], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "November 2026", "files": {"html": "ny-nonmetropolitan-area/life-sciences/2026-10.html", "pdf": "ny-nonmetropolitan-area/life-sciences/2026-10.pdf"}, "published_at": "2026-11-03T08:27:21.225501+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/ny-nonmetropolitan-area/life-sciences/2026-10.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/ny-nonmetropolitan-area/life-sciences/2026-10.pdf"}